Literature DB >> 1835906

5'-Deoxy-5-fluorouridine improves cachexia by a mechanism independent of its antiproliferative action in colon 26 adenocarcinoma-bearing mice.

H Eda1, Y Tanaka, H Ishitsuka.   

Abstract

The cytostatic agent 5'-deoxy-5-fluorouridine (5'-dFUrd) improves cachexia and prolongs survival, suppressing tumor growth in mice bearing large burdens of colon 26 adenocarcinoma. To investigate the mode of this anticachectic action, we isolated colon 26 variants that were resistant to the anticachectic activity in vivo in tumor-bearing mice that initially responded to 5'-dFUrd in terms of tumor growth and cachexia but again became cachectic and refractory to the drug after prolonged treatment. The original line and variants were equally susceptible to the antiproliferative action of 5'-dFUrd, and their growth was stopped. However, 5'-dFUrd given to cachectic mice exhibiting large burdens of these variants could not reverse wasting and only slightly prolonged the survival period. These results indicate that the anticachectic activity of 5'-dFUrd is independent of its antiproliferative action and that the survival of colon 26-bearing mice is shorter when the size of the tumors is not reduced to levels below those that cause cachexia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835906     DOI: 10.1007/bf00686327

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  15 in total

1.  Specific determination of blood glucose with o-toluidine.

Authors:  A HYVARINEN; E A NIKKILA
Journal:  Clin Chim Acta       Date:  1962-01       Impact factor: 3.786

2.  Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.

Authors:  A Kono; Y Hara; S Sugata; Y Karube; Y Matsushima; H Ishitsuka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-01       Impact factor: 1.645

3.  Anticachectic activity of 5'-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma.

Authors:  Y Tanaka; H Eda; K Fujimoto; T Tanaka; T Ishikawa; H Ishitsuka
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

4.  5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow.

Authors:  R D Armstrong; E Cadman
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

5.  Role of interleukin-1 in the depression of liver drug metabolism by endotoxin.

Authors:  P Ghezzi; B Saccardo; P Villa; V Rossi; M Bianchi; C A Dinarello
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

6.  Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice.

Authors:  P Ghezzi; B Saccardo; M Bianchi
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

7.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

8.  Comparative studies on the immunosuppressive effect among 5'-deoxy-5-fluorouridine, ftorafur, and 5-fluorouracil.

Authors:  Y Ohta; K Sueki; K Kitta; K Takemoto; H Ishitsuka; Y Yagi
Journal:  Gan       Date:  1980-04

9.  Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those with early transplants.

Authors:  Y Tanaka; T Tanaka; H Ishitsuka
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

10.  Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.

Authors:  G J Peters; B J Braakhuis; E A de Bruijn; E J Laurensse; M van Walsum; H M Pinedo
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

View more
  3 in total

Review 1.  New drugs for the anorexia-cachexia syndrome.

Authors:  Mellar P Davis
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

2.  Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma.

Authors:  T Matsumoto; K Fujimoto-Ouchi; S Tamura; Y Tanaka; H Ishitsuka
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

3.  Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.

Authors:  H J Hussey; P T Todorov; W N Field; N Inagaki; Y Tanaka; H Ishitsuka; M J Tisdale
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.